tirzepatide urinary tract infection 🚨 New Research Alert! 🚨 From @sexmedresearch For the first time, a GLP-1/GIP medication (tirzepatide) has been shown to successfully treat Persistent Genital Arousal Disorder (PGAD/GPD) — a rare, painful, and often Renal effects and safety of

After six months, the goal shifts from repair to optimization. Long-term users generally report a higher baseline of health

Three major The End of the "Animal Model" Era: Navigating the 2025 NIH Funding Shift Jan 3, 2026 The End of the "Animal Model" Era: Navigating the 2025 NIH Funding Shift For decades, animal models were considered the gold standard for drug safety and efficacy

Statements Author contributions WZ: Conceptualization, Data curation, Writing original draft

By slowing digestion and signaling fullness, Semaglutide makes it easier to eat less without constant hunger

It may be possible in certain cases, but only with medical supervision